One platform connecting startups, corporations, research institutions, regions and investors
Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
4 Cold Chain Models Vietnamese Exporters Should Consider
1. Technology overview
Cancilico is a company based in Dresden, Germany, developing AI-assisted bone marrow morphology for hematology labs. Manual differentiation of bone marrow smears is slow and varies between readers, which delays blood cancer diagnostics.
Its product MyeloAID counts and classifies cells and produces a detailed, reproducible myelogram in minutes. It works with the microscope or scanner a lab already owns, so no dedicated appliance is required. The models are trained on curated proprietary datasets of healthy and diseased marrow labelled by more than ten morphology experts. Partner logos include Novartis, Servier and EKFZ for Digital Health.
2. Highlighted features & specifications
- Cell counting: counts cells on bone marrow smears.
- Cell classification: differentiates bone marrow cell types by morphology.
- Myelogram report: produces a detailed, reproducible myelogram in minutes.
- Hardware-agnostic: works with a lab's existing microscope or scanner.
- Expert-labelled training data: models trained on proprietary data labelled by over ten morphology experts.
- Proficiency testing: MyeloAID met the INSTAND scheme criteria for bone marrow cytology.
3. Potential application
Hematology labs at large Vietnamese hospitals could use it as a second reader for bone marrow smears. Research and pharma partners could use it for standardised cell counts in trials. Clinical use would depend on local regulatory approval.
4. Benefits
Produces a myelogram in minutes instead of manual counting. Results are reproducible across readers. Works with existing microscopes and scanners, avoiding new equipment. A GDPR program with data protection officer and DPIAs supports data handling.
5. Market trends & opportunities
Digital and AI-assisted pathology is moving into routine hematology as labs face specialist shortages. Vietnamese hematology and oncology hospitals handling growing blood cancer caseloads could benefit, subject to regulatory clearance for clinical use.
6. Other information
Cancilico, Tatzberg 47, 01307 Dresden, Germany. Hiring a Regulatory Affairs Manager in October 2026. Co-financed from Saxon state budget funds. MyeloAID met INSTAND proficiency test criteria in September 2026.
